2021
DOI: 10.35754/0234-5730-2021-66-3-458-470
|View full text |Cite
|
Sign up to set email alerts
|

Vaccination against COVID-19 for hematologic patients: A review of clinical guidelines

Abstract: Introduction. The COVID-19 pandemic has led to the need to accelerate the development of vaccines targeting SARSCoV-2. A large number of researchers have already confi rmed that patients with cancer have a high risk of mortality from COVID-19. Hematologic diseases and the therapy of these diseases are very heterogeneous, therefore it is expected that the immune response to infection or vaccination will be more variable in this cohort of patients. Accordingly, questions arise regarding the safety and effi cacy … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 40 publications
0
0
0
Order By: Relevance